These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12649355

  • 1. The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis.
    Sasaki M, Bharwani S, Jordan P, Joh T, Manas K, Warren A, Harada H, Carter P, Elrod JW, Wolcott M, Grisham MB, Alexander JS.
    J Pharmacol Exp Ther; 2003 Apr; 305(1):78-85. PubMed ID: 12649355
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Paradoxical roles of different nitric oxide synthase isoforms in colonic injury.
    Beck PL, Xavier R, Wong J, Ezedi I, Mashimo H, Mizoguchi A, Mizoguchi E, Bhan AK, Podolsky DK.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G137-47. PubMed ID: 14665440
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity.
    Vallance BA, Dijkstra G, Qiu B, van der Waaij LA, van Goor H, Jansen PL, Mashimo H, Collins SM.
    Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G865-74. PubMed ID: 15217783
    [Abstract] [Full Text] [Related]

  • 8. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
    Yu Y, Ohmori K, Chen Y, Sato C, Kiyomoto H, Shinomiya K, Takeuchi H, Mizushige K, Kohno M.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):904-13. PubMed ID: 15312879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
    Naito Y, Takagi T, Uchiyama K, Kuroda M, Kokura S, Ichikawa H, Yanagisawa R, Inoue K, Takano H, Satoh M, Yoshida N, Okanoue T, Yoshikawa T.
    Int J Mol Med; 2004 Aug 18; 14(2):191-6. PubMed ID: 15254764
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dextran sodium sulfate-induced colitis reveals nicotinic modulation of ion transport via iNOS-derived NO.
    Green CL, Ho W, Sharkey KA, McKay DM.
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep 18; 287(3):G706-14. PubMed ID: 15087277
    [Abstract] [Full Text] [Related]

  • 14. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J, de Vera J, Narushima S, Beck EX, Palencia S, Shinkawa P, Kim KA, Liu Y, Levy MD, Berg DJ, Abo A, Funk WD.
    Gastroenterology; 2007 Apr 18; 132(4):1331-43. PubMed ID: 17408649
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phenyl methimazole suppresses dextran sulfate sodium-induced murine colitis.
    Benavides U, Gonzalez-Murguiondo M, Harii N, Lewis CJ, Sakhalkar HS, Deosarkar SP, Kurjiaka DT, Dagia NM, Goetz DJ, Kohn LD.
    Eur J Pharmacol; 2010 Sep 15; 643(1):129-38. PubMed ID: 20550948
    [Abstract] [Full Text] [Related]

  • 17. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
    Kwon KH, Murakami A, Tanaka T, Ohigashi H.
    Biochem Pharmacol; 2005 Feb 01; 69(3):395-406. PubMed ID: 15652231
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
    Takayama M, Matsubara M, Arakawa E, Takada C, Ina Y, Hasegawa K, Yao K.
    Vascul Pharmacol; 2007 Apr 01; 46(4):302-8. PubMed ID: 17197250
    [Abstract] [Full Text] [Related]

  • 20. Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model.
    Ugawa T, Kakuta H, Moritani H, Shikama H.
    Br J Pharmacol; 2002 Mar 01; 135(6):1572-8. PubMed ID: 11906972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.